Symbiosis rolls out first 10,000 vial batch at Stirling Facility
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new plant will manufacture high-quality Type I borosilicate glass tubing
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Subscribe To Our Newsletter & Stay Updated